ZYPEPTRI
Live / Applied — First extension granted (statement of use) (as of 20 Feb 2026)
What this means for you
Not registered yet, but its 03 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99026510
- Mark type
- Stylized text
- Filed
- 03 Feb 2025
- Published for opposition
- 08 Apr 2025
- Attorney of record
- CHERYL L. FOYTLIN
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 21 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Feb 2026 — SOU EXTENSION 1 GRANTED
- 20 Feb 2026 — SOU EXTENSION 1 FILED
- 20 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Jul 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 31 Jul 2025 — OPPOSITION TERMINATED NO. 999999
- 31 Jul 2025 — OPPOSITION DISMISSED NO. 999999
- 17 Jun 2025 — ASSIGNED TO EXAMINER
- 09 Jun 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 09 Jun 2025 — OPPOSITION INSTITUTED NO. 999999
- 07 May 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED